Oxford Science Enterprises
Overview
Oxford Science Enterprises is an independent investment company and venture builder that partners with the University of Oxford to found, fund, and build businesses in the life sciences, health technology, and deep technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wild Bioscience | Jul 2026 | Series A | Co-investor |
| Mirae | Jul 2026 | Seed | Lead |
| Mirae Corporation | Jul 2026 | Seed | Lead |
| Vivid Dx | Jul 2026 | Seed | Lead |
| Moa Technology | Jul 2026 | Series C | Lead |
Key People
Craig Fox
Operating Partner (Lifesciences)
Scott Ellis
Scientific Operating Partner
Claire Brown
Partner ( Life Sciences)
Joel Schoppig
Partner
Nick Dixon-Clegg
Partner
Sam Harman
Partner, Head of Deep Tech
Sanne de Jongh
VC Partner
Polly Elvin
Head Of Investor Relations And Co-investors
George Todd
Principal
Liliane Chamas
Healthtech Principal
Oliver Mahony
Principal
Richard Oakley
Principal
Sally Dewhurst
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?